ONKOSXCEL THERAPEUTICS

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ONKOSXCEL THERAPEUTICS was filed as Word mark on 09/16/2022 at the World Intellectual Property Organization.

Trademark Details Last update: August 10, 2023

Trademark form Word mark
File reference 1690850
Countries Australia Brazil Canada Switzerland China European Community United Kingdom Japan South Korea Mexico
Base trademark US No. , November 27, 2024
Application date September 16, 2022
Expiration date September 16, 2032

Trademark owner

555 Long Wharf Drive, 12th Floor
New Haven CT 06511
US

Trademark representatives

1299 Pennsylvania Avenue, NW, Suite 700 US

goods and services

05 Pharmaceuticals; pharmaceutical preparations: biopharmaceuticals; biopharmaceutical preparations: pharmaceuticals and biopharmaceuticals for the treatment of oncology; pharmaceuticals and biopharmaceuticals for the treatment of immuno-oncology; pharmaceuticals and biopharmaceuticals for the treatment of cancer, tumor, prostate cancer, castration resistant prostate cancer, neuro endocrine tumors, small cell neuroendocrine cancer, small cell lung cancer, adenocarcinoma, melanoma, sarcoma, soft tissue sarcoma, acute myeloid leukemia, head and neck cancers, pancreatic cancer, neuroendocrine prostate cancer
42 Pharmaceutical research services; biopharmaceutical research services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical drug development services; development of pharmaceutical and biopharmaceutical preparations and medicines

Trademark history

Date Document number Area Entry
July 27, 2023 2023/32 Gaz RAW: Limitation
July 3, 2023 2023/27 Gaz CN Rejection
March 9, 2023 2023/10 Gaz EM Rejection
January 18, 2023 2023/3 Gaz GB Rejection
January 11, 2023 2023/2 Gaz AU Rejection
September 16, 2022 2022/40 Gaz US Registration

ID: 141690850